Single-Blind, Randomized Study of the Comparative Drug Likeability and Pharmacokinetics of Vyvanse and ADDERALL XR When Administered as a Solution.
Phase of Trial: Phase I
Latest Information Update: 27 Mar 2015
At a glance
- Drugs Lisdexamfetamine (Primary) ; Mixed amfetamine salts (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacokinetics
- Sponsors Shire
- 07 Apr 2009 Planned end date changed from 1 Oct 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
- 07 Apr 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 07 Apr 2009 Actual patient number (3) added as reported by ClinicalTrials.gov.